FIELD: medicine.
SUBSTANCE: invention relates to gel composition for nasal introduction of neurotransmitters. Composition includes, at least, one neurotransmitter, for instance, such as dopamine; at least, one lipophilic or partially lipophilic carrier; and compound or mixture of compounds, possessing activity with respect to reduction of superficial tension, in amount, efficient for formation of emulsion in situ when composition contacts water.
EFFECT: composition ensures high bioactivity and bioavailability of neurotransmitter in plasma and brain.
14 cl, 3 dwg, 2 tbl, 1 ex
Authors
Dates
2013-04-27—Published
2007-09-27—Filed